Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Noxafil (posaconazole) Oral Suspension
Company: Schering Corporation
NDA: 22027
Approval Date: 10/20/2006


Date created: September 5, 2008

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.